(Q54481085)

English

Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

1 reference

based on heuristic

inferred from title

author name string

S L Murray

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

E M Du Vall

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

L M Slater

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

publication date

1 January 1984

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

13

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

69-70

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

https://scigraph.springernature.com/pub.10.1007/bf00401452

0 references

Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/6733845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6733845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/6733845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/6733845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6733845

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00401452

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/6733845

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54481085&oldid=1584565841"